ClinicoEconomics and Outcomes Research

Improving Data Collection and Analysis of Costs and Quality-of-Life Measures to Address Health Disparities

Value assessment is intended as a tool for evaluating treatments to gauge value and inform decisions. Value assessments typically incorporate a cost-effectiveness analysis (CEA), focusing on costs and health outcomes important to payers, but missing important information to optimize resource allocation at a societal level. Despite frequent calls for more explicit consideration of health equity impacts in value assessment, health economists continue to develop models informed by traditional cost and quality-of-life (QoL) data that do not capture differences experienced by health disparity populations. This Article Collection contains original research, systematic reviews, and commentaries that explore costs and QoL data collection and dissemination in a way that incorporates more subgrouping and other methods that can support evaluation of cost-effectiveness in disadvantaged groups compared to advantaged groups.